NFKB1 and neoplasm: Successful generation of this model provides unique insight into the role of NF-κB activation in different phases of ovarian cancer progression, effects of modulating NF-κB activity on host cell immune responses in the tumor microenvironment, and will serve as a powerful tool for pre-clinical testing of agents that target NF-κB in ovarian cancer.